Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma

BACKGROUND: The treatment of acute lymphoblastic leukemia (ALL) and osteosarcoma (OSC) is very effective: the vast majority of patients recover and survive for decades. However, they still need to face serious adverse effects of chemotherapy. One of these is cardiotoxicity which may lead to progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Sági, Judit C., Egyed, Bálint, Kelemen, Andrea, Kutszegi, Nóra, Hegyi, Márta, Gézsi, András, Herlitschke, Martina Ayaka, Rzepiel, Andrea, Fodor, Lili E., Ottóffy, Gábor, Kovács, Gábor T., Erdélyi, Dániel J., Szalai, Csaba, Semsei, Ágnes F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029426/
https://www.ncbi.nlm.nih.gov/pubmed/29970035
http://dx.doi.org/10.1186/s12885-018-4629-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029426/
https://www.ncbi.nlm.nih.gov/pubmed/29970035
http://dx.doi.org/10.1186/s12885-018-4629-6

Ejemplares similares